Safety, Efficacy of an Accelerated Regimen of Low-Dose Recombinant Tissue-Type Plasminogen Activator for Reperfusion Therapy of Acute Pulmonary Embolism
Controversy persists regarding the safety and efficacy of an accelerated low-dose recombinant tissue-type plasminogen activator (rt-PA) regimen for reperfusion therapy in acute pulmonary embolism. This study describes the outcomes of an accelerated low-dose rt-PA regimen for the treatment of acute p...
Main Authors: | Bui Hai Hoang MD, PhD, Phuc Giang Do MD, MSc, Lac Duy Le MD, Thao Thi Huong Bui Pharmacist, MSc, Thinh Nghia Bui MD, MSc, Quan Minh Nguyen MD, PhD, Duong Hoang To MD, MSc, Anh Dat Nguyen MD, PhD, Michael M. Dinh MD, PhD, Samuel Z. Goldhaber MD, PhD, Richard Day, Hieu Lan Nguyen MD, PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-09-01
|
Series: | Clinical and Applied Thrombosis/Hemostasis |
Online Access: | https://doi.org/10.1177/10760296211037920 |
Similar Items
-
Immunotherapy of Cancer: Developments and Reference Points, an Unorthodox Approach
by: Michail Nikolaou MD, MSc, PhD, et al.
Published: (2019-01-01) -
Uninterrupted dabigatran is safer than warfarin in patients undergoing ablation for atrial fibrillation
by: Michael Spartalis, MD, MSc, PhD, et al.
Published: (2017-12-01) -
Immunohistochemical Expression of Cyclooxygenases in Hypertrophic Scars and Keloids
by: Michel Pavelecini, MD, MSc, PhD, et al.
Published: (2019-02-01) -
Impact of COVID-19 Lockdown on Pulmonary and Nutritional Status in Children and Young Adults With Cystic Fibrosis, in Greece
by: Ioanna Loukou MD, PhD, MSc, et al.
Published: (2021-04-01) -
Curcumin Acts as a Chemosensitizer for Leiomyosarcoma Cells In Vitro But Fails to Mediate Antioxidant Enzyme Activity in Cisplatin-Induced Experimental Nephrotoxicity in Rats
by: Irida Dhima MSc, PhD, et al.
Published: (2019-08-01)